December 4th, 2018 - New iPSC Lines Created for Clinical Development
October 31st, 2018 - Allele Receives iPSC Patents Bolstering Current Production of Multiple Lines at Wholly Owned cGMP Facility
January 6th, 2017 - Allele Biotechnology to Develop iPSC-Derived Cell Therapies with Focus on Diabetes and Spinal Cord Injury